Annual EBITDA
$251.71M$38.86M-13.37%
Summary
- Current Value
- As of today, STVN annual EBITDA is $251.71M, down -13.37% on
- Historical Performance
- STVN annual EBITDA is up +1.79% over the past 3 years, and up +125.57% over the past 5 years
- All-Time High Comparison
- STVN annual EBITDA is currently -13.37% below its historical high of $290.58M set on
- 3-Year Low Comparison
- STVN annual EBITDA is +0.46% above its 3-year low of $250.56M reached on an earlier date
- Sector Comparison
- STVN annual EBITDA is higher than 89.04% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $251.71M | -13.4% | +1.8% | +125.6% | – | |
| Quarterly EBITDA | $83.88M | +31.2% | +34.7% | +107.9% | – | |
| TTM EBITDA | $297.70M | +19.4% | +23.3% | +163.0% | – | |
| Price | $21.06 | -12.0% | +5.3% | – | – | |
| PE Ratio | 37.02 | -27.6% | +4.5% | – | – | |
| Annual Revenue | $1.19B | +1.8% | +19.7% | +98.9% | – | |
| Annual EPS | $0.47 | -20.9% | -21.7% | +183.3% | – | |
| Annual EBIT | $167.30M | -18.7% | -8.0% | +179.5% | – | |
| Annual Net Income | $127.39M | -19.1% | -19.7% | +194.0% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $290.58M | -13.4% | |
| 5Y | $290.58M | -13.4% | |
| All | $290.58M | -13.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $250.56M | N/A | +0.5% |
| 5Y | $173.25M | N/A | +45.3% |
| All | $111.59M | +125.6% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $251.71M | -13.4% | |
| $290.58M | +16.0% | |
| $250.56M | +1.3% |
| Year | Value | Change |
|---|---|---|
| $247.30M | +42.7% | |
| $173.25M | +55.3% | |
| $111.59M | - |
FAQ
What is the current annual EBITDA of STVN?
As of today, STVN annual EBITDA is $251.71M
What is 1-year change in STVN annual EBITDA?
STVN annual EBITDA is down -13.37% year-over-year
What is 3-year change in STVN annual EBITDA?
STVN annual EBITDA is up +1.79% over the past 3 years
How far is STVN annual EBITDA from its all-time high?
STVN annual EBITDA is currently -13.37% below its historical high of $290.58M set on December 31, 2023
How does STVN annual EBITDA rank versus sector peers?
STVN annual EBITDA is higher than 89.04% of companies in Healthcare sector
When is STVN next annual earnings release?
The next annual earnings release for STVN is on
Quarterly EBITDA
$83.88M$13.52M+19.22%
Summary
- Current Value
- As of today, STVN quarterly EBITDA is $83.88M, up +19.22% on
- Historical Performance
- STVN quarterly EBITDA is up +31.21% year-over-year, and up +34.67% over the past 3 years
- All-Time High Comparison
- STVN quarterly EBITDA is currently -3.84% below its historical high of $87.23M set on
- 3-Year Low Comparison
- STVN quarterly EBITDA is +72.13% above its 3-year low of $48.73M reached on
- Sector Comparison
- STVN quarterly EBITDA is higher than 88.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $83.88M | +19.2% | +31.2% | +34.7% | +107.9% | |
| Annual EBITDA | $251.71M | – | -13.4% | +1.8% | +125.6% | |
| TTM EBITDA | $297.70M | +7.2% | +19.4% | +23.3% | +163.0% | |
| Price | $21.06 | -13.6% | -12.0% | +5.3% | – | |
| PE Ratio | 37.02 | -13.6% | -27.6% | +4.5% | – | |
| Quarterly Revenue | $354.27M | +11.5% | +16.1% | +43.5% | +93.0% | |
| Quarterly EPS | $0.15 | +25.1% | +27.7% | +12.1% | +110.3% | |
| Quarterly EBIT | $58.43M | +27.3% | +33.8% | +31.6% | +126.2% | |
| Quarterly Net Income | $42.14M | +25.1% | +27.8% | +15.3% | +116.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $86.51M | N/A | -3.0% |
| 3Y | $87.23M | -3.8% | |
| 5Y | $87.23M | -3.8% | |
| All | $87.23M | -3.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $56.95M | +47.3% | |
| 3Y | $48.73M | +72.1% | |
| 5Y | $47.92M | +75.0% | |
| All | $30.23M | +177.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of STVN?
As of today, STVN quarterly EBITDA is $83.88M
What is STVN quarterly EBITDA most recent change?
STVN quarterly EBITDA was up +19.22% on September 30, 2025
What is 1-year change in STVN quarterly EBITDA?
STVN quarterly EBITDA is up +31.21% year-over-year
How far is STVN quarterly EBITDA from its all-time high?
STVN quarterly EBITDA is currently -3.84% below its historical high of $87.23M set on December 31, 2023
How does STVN quarterly EBITDA rank versus sector peers?
STVN quarterly EBITDA is higher than 88.05% of companies in Healthcare sector
When is STVN next earnings release?
The next earnings release for STVN is on
TTM EBITDA
$297.70M$19.95M+7.18%
Summary
- Current Value
- As of today, STVN TTM EBITDA is $297.70M, up +7.18% on
- Historical Performance
- STVN TTM EBITDA is up +19.37% year-over-year, and up +23.31% over the past 3 years
- All-Time High Comparison
- STVN TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- STVN TTM EBITDA is +19.71% above its 3-year low of $248.67M reached on
- Sector Comparison
- STVN TTM EBITDA is higher than 87.78% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $297.70M | +7.2% | +19.4% | +23.3% | +163.0% | |
| Annual EBITDA | $251.71M | – | -13.4% | +1.8% | +125.6% | |
| Quarterly EBITDA | $83.88M | +19.2% | +31.2% | +34.7% | +107.9% | |
| Price | $21.06 | -13.6% | -12.0% | +5.3% | – | |
| PE Ratio | 37.02 | -13.6% | -27.6% | +4.5% | – | |
| TTM Revenue | $1.29B | +3.9% | +9.2% | +29.5% | +152.8% | |
| TTM EPS | $0.57 | +6.3% | +23.1% | -0.3% | +198.9% | |
| TTM EBIT | $205.07M | +7.8% | +24.7% | +19.6% | +191.3% | |
| TTM Net Income | $155.26M | +6.3% | +25.0% | +2.6% | +209.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $297.70M | at high | |
| 3Y | $297.70M | at high | |
| 5Y | $297.70M | at high | |
| All | $297.70M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $248.67M | N/A | +19.7% |
| 3Y | $248.67M | +19.7% | |
| 5Y | $146.07M | +103.8% | |
| All | $30.23M | +884.6% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of STVN?
As of today, STVN TTM EBITDA is $297.70M
What is STVN TTM EBITDA most recent change?
STVN TTM EBITDA was up +7.18% on September 30, 2025
What is 1-year change in STVN TTM EBITDA?
STVN TTM EBITDA is up +19.37% year-over-year
How far is STVN TTM EBITDA from its all-time high?
STVN TTM EBITDA is currently at its all-time high
How does STVN TTM EBITDA rank versus sector peers?
STVN TTM EBITDA is higher than 87.78% of companies in Healthcare sector
When is STVN next earnings release?
The next earnings release for STVN is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- STVN Official Website www.stevanatogroup.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1849853/000119312525269425/0001193125-25-269425-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1849853/000095017025034633/0000950170-25-034633-index.htm
- STVN Profile on Yahoo Finance finance.yahoo.com/quote/STVN
- STVN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/stvn